A Study to Evaluate the Experiences of Discrimination, Harassment, and Inclusion During Training and Climate Survey Development of Hematology/Oncology Fellows

Overview

About this study

The purpose of this study is to gain a detailed understanding of the current landscape of bias and/or discrimination involving hematology/oncology fellows at Mayo Clinic Rochester including the prevalence, source, and type of discrimination/harassment.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • All hematology and oncology fellows (including advanced fellows) are eligible for the study.

Exclusion Criteria:

  • Hematology/oncology fellows no longer in training.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Katharine Price, M.D.

Contact us for the latest status

Contact information:

Rahma Warsame M.D.

Warsame.Rahma@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20446938

Mayo Clinic Footer